St. Jude Family of Websites
Explore our cutting edge research, world-class patient care, career opportunities and more.
St. Jude Children's Research Hospital Home
- Fundraising
St. Jude Family of Websites
Explore our cutting edge research, world-class patient care, career opportunities and more.
St. Jude Children's Research Hospital Home
St. Jude Family of Websites
Explore our cutting edge research, world-class patient care, career opportunities and more.
St. Jude Children's Research Hospital Home
Associate Member, St. Jude Faculty
On this page:
Anna Vinitsky, MD, MS
Neuro-Oncology
MS 260, Room C6068
St. Jude Children's Research Hospital
262 Danny Thomas Place
Memphis, TN 3810-3678
MD - Minsk State Medical Institute, Minsk, Belarus MS - Medical College of Wisconsin, Milwaukee, Wisconsin Residency (Pediatrics) - Marshfield Clinic-Saint Joseph’s Children’s Hospital of Marshfield, Marshfield, Wisconsin Fellowship (Pediatric Hematology/Oncology) – Medical College of Wisconsin, Milwaukee, Wisconsin Fellowship (Pediatric Neuro-Oncology) – St. Jude Children’s Research Hospital
Study goal:
The main goal of this study is to test the experimental drug mirdametinib in hopes of finding a treatment that may be effective against low-grade glioma brain tumors in children, adolescents and young adults.
Age:
At least 2 years old and younger than 25 years old.
Study goal:
To see if savolitinib is safe and tolerable in children with brain tumors
Age:
Between 5 years old and 21 years old
Study goal:
To see how well children with high-grade glioma and ependymoma can use the Optune device and what side effects it may cause; and to see if Optune and radiation therapy are safe and effective for diffuse intrinsic pontine glioma.
Age:
3-21 years